Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman

Area of Science:

• Cardiovascular Physiology
• Molecular Cardiology
• Biochemistry

Background:

• Elevated intracellular sodium ([Na]i) in the failing heart impairs contractility and promotes arrhythmias.
• Phospholemman (PLM) regulates Na/K pump activity, but its role in disease-related sodium overload is unclear.

Purpose of the Study:

• To investigate if preventing PLM phosphorylation exacerbates cardiac hypertrophy and sodium overload.
• To determine if PLM phosphorylation defects causally contribute to heart failure progression.

Main Methods:

• Utilized a PLM(3SA) knock-in mouse model where PLM phosphorylation is prevented.
• Induced cardiac stress via aortic constriction in both wild-type and PLM(3SA) mice.
• Assessed cardiac function, hypertrophy, [Na]i, and Na/K pump activity using echocardiography, morphometry, and electrophysiology.

Main Results:

• Aortic constriction led to PLM hypophosphorylation, reduced Na/K pump current, and elevated [Na]i in wild-type mice.
• PLM(3SA) mice exhibited exacerbated cardiac hypertrophy, Na/K pump inhibition, and contractile dysfunction compared to wild-type mice post-banding.
• Increased Na/K ATPase expression in PLM(3SA) myocytes did not fully compensate for reduced PLM phosphorylation.

Conclusions:

• Decreased PLM phosphorylation significantly impairs Na/K pump activity, leading to sodium overload and worsening cardiac dysfunction.
• These findings highlight a critical role for PLM phosphorylation in maintaining cardiac function during stress.
• Targeting PLM phosphorylation presents a novel therapeutic strategy for heart failure.